NRGCNMDA: Microbe-Drug Association Prediction Based on Residual Graph Convolutional Networks and Conditional Random Fields

The process of discovering new drugs related to microbes through traditional biological methods is lengthy and costly. In response to these issues, a new computational model (NRGCNMDA) is proposed to predict microbe-drug associations. First, Node2vec is used to extract potential associations between microorganisms and drugs, and a heterogeneous network of microbes and drugs is constructed. Then, a Graph Convolutional Network incorporating a fusion residual network mechanism (REGCN) is utilized to learn meaningful high-order similarity features. In addition, conditional random fields (CRF) are applied to ensure that microbes and drugs have similar feature embeddings. Finally, unobserved microbe-drug associations are scored based on combined embeddings. The experimental findings demonstrate that the NRGCNMDA approach outperforms several existing deep learning methods, and its AUC and AUPR values are 95.16% and 93.02%, respectively. The case study demonstrates that NRGCNMDA accurately predicts drugs associated with Enterococcus faecalis and Listeria monocytogenes, as well as microbes associated with ibuprofen and tetracycline.